BlackRock Japan’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

BlackRock Japan’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4	Closed	-$4K	–	1408
2015 Q1	$4K	Hold	4	–	–	﹤0.01%	1282
2014 Q4	$5K	Hold	4	–	–	﹤0.01%	1307
2014 Q3	$5K	Hold	4	–	–	﹤0.01%	1242
2014 Q2	$9K	Hold	4	–	–	﹤0.01%	1210
2014 Q1	$9K	Buy	+4	New	+$9.96K	﹤0.01%	1349

Other funds holding ONCT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock Japan's ONCT Position: Q2 2015 in Review

BlackRock Japan sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2015, closing a stake of 4 shares — an estimated $4K sold.

BlackRock Japan first reported a position in ONCT in Q1 2014 and held it in 5 quarters. The position peaked at $9K in Q2 2014. 38 funds tracked by Wall St. Rank hold ONCT as of Q2 2015.

BlackRock Japan reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
BlackRock Japan sold 4 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $4K.
BlackRock Japan first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2014 and held it in 5 quarters.
BlackRock Japan's Oncternal Therapeutics, Inc. Common Stock position peaked at $9K in Q2 2014.
38 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2015.

Based on BlackRock Japan's 13F filing for Q2 2015, filed 7 Aug 2015.